Save
R
N
L
e
a
r
ni
n
g
S
y
st
e
m
P
h
a
r
m
a
c
ol
o
g
y
Fi
n
al
Q
ui
z
Students
also
studied
, Terms in this set (50)
A nurse is assessing a client who reports using several herbal and vitamin supplements daily, including saw palmetto.
The nurse should recognize that saw palmetto is a supplement used by clients to elicit which of the following therapeutic
effects?
A. Urinary health promotion
B. Immune system stimulation
C. Decreased leg pain from arterial disease
D. Prevention of nausea caused by motion sickness
A. Urinary health promotion
Explanation: Saw palmetto is used primarily for manifestations related to prostatic conditions, such as benign prostatic
hypertrophy (BPH). Its effectiveness has not been scientifically proven, however. The nurse should teach the client to
check with the provider about interactions between saw palmetto and other medications.
B.Echinacea is a popular herb widely used in the U.S. primarily to reduce the manifestations and duration of colds and
flu-like illnesses, although its effectiveness has not been proven.
C. Ginkgo biloba has become a widely used dietary supplement in the United States for increasing cognitive functions in
elderly people, although this effect has not been proven. Ginkgo has been shown to improve leg pain of intermittent
claudication and other peripheral arterial disorders.
D. Ginger root is sometimes used to prevent and treat nausea caused by motion sickness, seasickness, and other
causes.
A nurse is preparing a discharge teaching plan for a 6-year-old client who has asthma and several prescription
medications using metered dose inhalers (MDIs). Which of the following interventions should the nurse include in the
plan?
A. Add a spacer to each MDI
B. Instruct the child to inhale more rapidly than usual when using an MDI
C. Request that the provider change the child's medications from inhaled to oral formulations.
D. Administer oxygen by facemask along with the MDI
A. Add a spacer to each MDI
Explanation: MDIs are difficult to use correctly and, even when properly used, only a portion of the medication is delivered
to the lungs. A spacer applied to an MDI can make up for lack of hand-lung coordination by increasing the amount of
medication delivered to the lungs.
B. The client who uses an inhaler should be taught to inhale the medication slowly over 3 to 5 seconds for maximum
effectiveness.
C. There are advantages to delivering medications for asthma by inhalation, including enhanced therapeutic effects,
decreased systemic adverse effects, and quick relief when short-acting bronchodilators are used. Changing the child's
medications to oral formulations is not an effective intervention.
D. Administering oxygen along with inhaled medications does not increase the amount of medication reaching the lungs.
In addition, oxygen therapy should be administered on the basis of low oxygen saturation and other assessments. It is
not appropriate to administer oxygen by facemask along with the MDI.
A nurse is providing teaching to a client who has postmenopausal osteoporosis and a new prescription for intranasal
calcitonin-salmon. Which of the following statements by the client indicates an understanding of the teaching?
A. "I will administer a spray into each nostril daily."
B. "I should expect nasal bleeding for the first week."
C. "I will need to depress the side arms to activate the pump."
D. "I should expect to take this medication for a short-term course of treatment."
C. "I will need to depress the side arms to activate the pump."
Explanation: The nurse should instruct the client to activate the pump on the initial use by holding the bottle upright and
depressing the two white side arms toward the bottle six times.
A. The nurse should instruct the client to administer calcitonin-salmon to one nostril daily, alternating nostrils.
B. The nurse should instruct the client that nasal bleeding, or ulcerations, are indications to discontinue the medication
and to notify the provider if nasal bleeding occurs.
D. Calcitonin-salmon is a long-term treatment therapy for postmenopausal osteoporosis. The medication has no
documented long-term adverse effects.
R
N
L
e
a
r
ni
n
g
S
y
st
e
m
P
h
a
r
m
a
c
ol
o
g
y
Fi
n
al
Q
ui
z
Students
also
studied
, Terms in this set (50)
A nurse is assessing a client who reports using several herbal and vitamin supplements daily, including saw palmetto.
The nurse should recognize that saw palmetto is a supplement used by clients to elicit which of the following therapeutic
effects?
A. Urinary health promotion
B. Immune system stimulation
C. Decreased leg pain from arterial disease
D. Prevention of nausea caused by motion sickness
A. Urinary health promotion
Explanation: Saw palmetto is used primarily for manifestations related to prostatic conditions, such as benign prostatic
hypertrophy (BPH). Its effectiveness has not been scientifically proven, however. The nurse should teach the client to
check with the provider about interactions between saw palmetto and other medications.
B.Echinacea is a popular herb widely used in the U.S. primarily to reduce the manifestations and duration of colds and
flu-like illnesses, although its effectiveness has not been proven.
C. Ginkgo biloba has become a widely used dietary supplement in the United States for increasing cognitive functions in
elderly people, although this effect has not been proven. Ginkgo has been shown to improve leg pain of intermittent
claudication and other peripheral arterial disorders.
D. Ginger root is sometimes used to prevent and treat nausea caused by motion sickness, seasickness, and other
causes.
A nurse is preparing a discharge teaching plan for a 6-year-old client who has asthma and several prescription
medications using metered dose inhalers (MDIs). Which of the following interventions should the nurse include in the
plan?
A. Add a spacer to each MDI
B. Instruct the child to inhale more rapidly than usual when using an MDI
C. Request that the provider change the child's medications from inhaled to oral formulations.
D. Administer oxygen by facemask along with the MDI
A. Add a spacer to each MDI
Explanation: MDIs are difficult to use correctly and, even when properly used, only a portion of the medication is delivered
to the lungs. A spacer applied to an MDI can make up for lack of hand-lung coordination by increasing the amount of
medication delivered to the lungs.
B. The client who uses an inhaler should be taught to inhale the medication slowly over 3 to 5 seconds for maximum
effectiveness.
C. There are advantages to delivering medications for asthma by inhalation, including enhanced therapeutic effects,
decreased systemic adverse effects, and quick relief when short-acting bronchodilators are used. Changing the child's
medications to oral formulations is not an effective intervention.
D. Administering oxygen along with inhaled medications does not increase the amount of medication reaching the lungs.
In addition, oxygen therapy should be administered on the basis of low oxygen saturation and other assessments. It is
not appropriate to administer oxygen by facemask along with the MDI.
A nurse is providing teaching to a client who has postmenopausal osteoporosis and a new prescription for intranasal
calcitonin-salmon. Which of the following statements by the client indicates an understanding of the teaching?
A. "I will administer a spray into each nostril daily."
B. "I should expect nasal bleeding for the first week."
C. "I will need to depress the side arms to activate the pump."
D. "I should expect to take this medication for a short-term course of treatment."
C. "I will need to depress the side arms to activate the pump."
Explanation: The nurse should instruct the client to activate the pump on the initial use by holding the bottle upright and
depressing the two white side arms toward the bottle six times.
A. The nurse should instruct the client to administer calcitonin-salmon to one nostril daily, alternating nostrils.
B. The nurse should instruct the client that nasal bleeding, or ulcerations, are indications to discontinue the medication
and to notify the provider if nasal bleeding occurs.
D. Calcitonin-salmon is a long-term treatment therapy for postmenopausal osteoporosis. The medication has no
documented long-term adverse effects.
